Literature DB >> 7636509

HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: the age-related pattern.

A M de Roda Husman1, J M Walboomers, E Hopman, O P Bleker, T M Helmerhorst, L Rozendaal, F J Voorhorst, C J Meijer.   

Abstract

Diverging data exist on human papillomavirus (HPV) prevalence in cytomorphologically normal scrapes during pregnancy. The prevalence of HPV was therefore investigated by polymerase chain reaction method (PCR) in cytomorphologically normal scrapes of 709 pregnant women and 3,948 non-pregnant women visiting the same hospital during the same time period. The prevalence of all types of HPV among pregnant women was 9.6% (68/709) and the high risk HPV types of 16 and 18 were found in 3.1% (22/709). In the non-pregnant women the prevalence of all types of HPV was 10.9% (432/3,948) with 2.9% (116/3,948) HPV types 16 and 18. The highest prevalence of HPV was present in women at younger ages in both groups. With increasing age the prevalence declines from about 19% (15-25 yrs) to 5% (40-49 yrs). The age-adjusted odds ratio of prevalence of all types of HPV in pregnant versus non-pregnant women was 0.73 (95% CI 0.56-0.96, P = 0.025) and statistically significant. When HPV types 16 and 18 were considered, significant differences were not found. HPV of all types and types 16/18 prevalence was higher in the second half of pregnancy than in the first part but did not reach statistical significance. High HPV copy numbers in the scrapes were found during the first half of the pregnancy and not during the second half using a semi-quantitative HPV 16/18 PCR detection method. Since the difference in HPV prevalence between non-pregnant and pregnant women is very small, it is concluded that HPV prevalence in cytomorphologically normal smears is hardly influenced by pregnancy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636509     DOI: 10.1002/jmv.1890460203

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  17 in total

1.  Screening for cervical cancer: should we test for infection with high-risk HPV?

Authors:  C J Meijer; P J Snijders; A J van den Brule
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

Review 2.  The role of vaccines in the control of STDs: HPV vaccines.

Authors:  I H Frazer
Journal:  Genitourin Med       Date:  1996-12

3.  Human papillomavirus is more prevalent in first trimester spontaneously aborted products of conception compared to elective specimens.

Authors:  P L Hermonat; L Han; P J Wendel; J G Quirk; S Stern; C L Lowery; T M Rechtin
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

4.  PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems.

Authors:  W Qu; G Jiang; Y Cruz; C J Chang; G Y Ho; R S Klein; R D Burk
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

5.  Oncogenic human papillomavirus (HPV) type distribution and HPV type 16 E6 variants in two Spanish population groups with different levels of HPV infection risk.

Authors:  M Ortiz; M Torres; L Muñoz; E Fernández-García; J Canals; A I Cabornero; E Aguilar; J Ballesteros; J Del Amo; A García-Sáiz
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

6.  HPV prevalence and concordance in the cervix and oral cavity of pregnant women.

Authors:  E M Smith; J M Ritchie; J Yankowitz; D Wang; L P Turek; T H Haugen
Journal:  Infect Dis Obstet Gynecol       Date:  2004-06

7.  HPV prevalence in Colombian women with cervical cancer: implications for vaccination in a developing country.

Authors:  Raúl Murillo; Mónica Molano; Gilberto Martínez; Juan-Carlos Mejía; Oscar Gamboa
Journal:  Infect Dis Obstet Gynecol       Date:  2009-12-20

Review 8.  The prevalence and risk of human papillomavirus infection in pregnant women.

Authors:  P Liu; L Xu; Y Sun; Z Wang
Journal:  Epidemiol Infect       Date:  2014-03-25       Impact factor: 4.434

9.  HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study.

Authors:  P Naucler; W Ryd; S Törnberg; A Strand; G Wadell; B G Hansson; E Rylander; J Dillner
Journal:  Br J Cancer       Date:  2007-06-05       Impact factor: 7.640

10.  High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum.

Authors:  M A E Nobbenhuis; T J M Helmerhorst; A J C van den Brule; L Rozendaal; P D Bezemer; F J Voorhorst; C J L M Meijer
Journal:  Br J Cancer       Date:  2002-07-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.